Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 92.00
-1.55 (-1.66%)
At close: Dec 5, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 157.67 billion as of December 5, 2025. Its market cap has increased by 155.34% in one year.
Market Cap
157.67B
Enterprise Value
150.92B
Revenue
12.52B
Ranking
n/a
PE Ratio
124.44
Stock Price
92.00
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 157.67B, an increase of 750.47%. That is a compound annual growth rate of 35.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 284.43B |
| Hansoh Pharmaceutical Group Company | 243.25B |
| JD Health International | 192.25B |
| WuXi Biologics | 126.66B |
| Sino Biopharmaceutical | 120.67B |
| Akeso | 108.88B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.74B |
| CSPC Pharmaceutical Group | 88.03B |